Sarah C. Garrett-Thomson

GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells

Eric L. Smith, Kim Harrington, Reed Masakayan et al. · Science Translational Medicine · 2019 · 373 citations · Full text

Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab

U.A. Ramagopal, Weifeng Liu, Sarah C. Garrett-Thomson et al. · Proceedings of the National Academy of Sciences · 2017 · 155 citations · Full text

Human Immune System, Immunology, Immunoediting +22

Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector

Eric L. Smith, Reed Masakayan, Ishan J. Tatake et al. · Molecular Therapy · 2018 · 125 citations · Full text

Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis

Natalia G. Herrera, Nicholas C. Morano, A. Celikgil et al. · ACS Omega · 2020 · 87 citations · Full text

Viral Replication, Viral Pathogenesis, Immunology +17

Structure and Cancer Immunotherapy of the B7 Family Member B7x

Hyungjun Jeon, Vladimir Vigdorovich, Sarah C. Garrett-Thomson et al. · Cell Reports · 2014 · 73 citations · Full text